Natera
In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health
A federal judge denied four motions by Guardant but granted four others by the company.
JP Morgan Healthcare Conference Day 1: Qiagen, Adaptive Bio, Guardant Health, Natera, Sema4
Highlights of the first day included Qiagen's strategy in the face of the COVID-19 pandemic and Adaptive Bio's development of its two major businesses.
In Brief This Week: Roche, Veracyte, Hologic, Danaher, Chembio Diagnostics, Natera, and More
News items for the in vitro diagnostics industry for the week of Nov. 29, 2021.
Invitae Sues Natera Over Alleged Infringement of Sequence Assembly Patents
Invitae is seeking damages and other costs, as well as an order enjoining Natera from infringing its '308 and '863 patents, which were granted last month.
Natera Accused of Unfair, Deceptive Billing Practices Related to NIPT Services in New Lawsuit
The plaintiff, a woman who'd used the company's Panorama test during a pregnancy, is asking the court to certify her case a class action.
Nov 4, 2021
Natera Q3 Revenues Grow 61 Percent
Aug 5, 2021
Natera Q2 Revenues Grow 64 Percent
Jul 21, 2021
Natera Prices, Upsizes Public Stock Offering
Jul 13, 2021
Natera Inks Distribution Deal With TomaLab for Italy
May 6, 2021